References:
- Perricone, C., Ceccarelli, F., Nesher, G. et al. Immune
thrombocytopenic purpura (ITP) associated with vaccinations: a review
of reported cases. Immunol Res 60, 226–235 (2014)
- Rodeghiero F, Stasi R, Gernsheimer T, et al.
Standardization of terminology, definitions and outcome criteria in
immune thrombocytopenic purpura of adults and children: report from an
international working group. Blood 2009; 113:2386.
- Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y.
Immune thrombocytopaenic purpura: an autoimmune cross-link between
infections and vaccines. Lupus. 2014;23:554–67.
- Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD,
Semple JW, Arnold DM, Godeau B, Lambert MP, Bussel JB.
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination.
American Journal of Hematology. 2021 Feb 19.
- Sanne E. de Jong, Axel Olin, Bali Pulendran, The Impact of the
Microbiome on Immunity to Vaccination in Humans. Cell Host & Microbe.
Volume 28, Issue 2 2020 ISSN 1931-3128.
- Cuker
A, Prak ET, Cines DB. Can immune thrombocytopenia be cured with
medical therapy? Semin Thromb Hemost 2015; 41:395.
- Gudbrandsdottir, S., Leven, E., Imahiyerobo, A., Lee, C.S. and Bussel,
J. (2020), Combination of thrombopoietin receptor agonists,
immunosuppressants and intravenous immunoglobulin as treatment of
severe refractory immune thrombocytopenia in adults and children. Br J
Haematol, 189: e37-e40.
- Charlotte A Bradbury, Rosemary
Greenwood,Julie Pell, Katie
Breheny,Rebecca
Kandiyali,Jenny Ingram,Ian
Thomas,Catherine Bagot, Quentin
Hill,Nichola Cooper. A multicentre randomised
trial of first line treatment pathways for newly diagnosed immune
thrombocytopenia: Standard steroid treatment versus combined steroid
and mycophenolate. the Flight Trial.Blood (2020) 136
(Supplement_2): LBA-2.
- Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of
two RNA‐based Covid‐19 vaccine candidates. N Engl J
Med. 2020; 383(25): 2439‐ 2450.